BR112013024630A2 - sistemas de expressão de gene regulados e constructos dos mesmos - Google Patents
sistemas de expressão de gene regulados e constructos dos mesmosInfo
- Publication number
- BR112013024630A2 BR112013024630A2 BR112013024630A BR112013024630A BR112013024630A2 BR 112013024630 A2 BR112013024630 A2 BR 112013024630A2 BR 112013024630 A BR112013024630 A BR 112013024630A BR 112013024630 A BR112013024630 A BR 112013024630A BR 112013024630 A2 BR112013024630 A2 BR 112013024630A2
- Authority
- BR
- Brazil
- Prior art keywords
- constructs
- gene expression
- regulated gene
- expression
- expression systems
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161467873P | 2011-03-25 | 2011-03-25 | |
| PCT/US2012/030602 WO2012135137A2 (en) | 2011-03-25 | 2012-03-26 | Regulated gene expression systems and constructs thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013024630A2 true BR112013024630A2 (pt) | 2019-09-24 |
Family
ID=46877663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013024630A BR112013024630A2 (pt) | 2011-03-25 | 2012-03-26 | sistemas de expressão de gene regulados e constructos dos mesmos |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9506072B2 (enExample) |
| EP (1) | EP2689017A4 (enExample) |
| JP (1) | JP2014518611A (enExample) |
| KR (1) | KR20140043890A (enExample) |
| CN (1) | CN104039964A (enExample) |
| AU (1) | AU2012236811A1 (enExample) |
| BR (1) | BR112013024630A2 (enExample) |
| CA (1) | CA2827774A1 (enExample) |
| GT (1) | GT201300220A (enExample) |
| IL (1) | IL228039A0 (enExample) |
| MX (1) | MX2013010872A (enExample) |
| NI (1) | NI201300094A (enExample) |
| PH (1) | PH12013501901A1 (enExample) |
| SG (1) | SG193356A1 (enExample) |
| WO (1) | WO2012135137A2 (enExample) |
| ZA (1) | ZA201306420B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017050920A1 (en) * | 2015-09-25 | 2017-03-30 | Acib Gmbh | Method for small molecule glycosylation |
| CN105802927B (zh) * | 2016-04-08 | 2019-07-26 | 暨南大学 | 一种6-磷酸葡萄糖脱氢酶及其编码基因和应用 |
| CN111100796B (zh) * | 2018-10-26 | 2021-07-09 | 中国石油化工股份有限公司 | 一种富含油脂的栅藻及其培养应用 |
| CN112194706B (zh) * | 2020-09-30 | 2022-03-08 | 广州派真生物技术有限公司 | 腺相关病毒突变体及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010528627A (ja) | 2007-06-01 | 2010-08-26 | ソラザイム、インク | 微生物による油の生産 |
| US9650642B2 (en) | 2008-02-08 | 2017-05-16 | Algenol Biotech LLC | Genetically modified cyanobacteria for the production of ethanol |
| CN101407824A (zh) * | 2008-11-24 | 2009-04-15 | 昆明理工大学 | 拟南芥细胞质型谷氨酰胺合成酶基因的植物表达载体的构建和应用 |
| ES2583639T3 (es) | 2008-11-28 | 2016-09-21 | Terravia Holdings, Inc. | Producción de aceites específicos en microorganismos heterótrofos |
| WO2012116345A2 (en) * | 2011-02-24 | 2012-08-30 | South Dakota State University | Genetically engineered cyanobacteria |
-
2012
- 2012-03-26 SG SG2013067400A patent/SG193356A1/en unknown
- 2012-03-26 PH PH1/2013/501901A patent/PH12013501901A1/en unknown
- 2012-03-26 AU AU2012236811A patent/AU2012236811A1/en not_active Abandoned
- 2012-03-26 WO PCT/US2012/030602 patent/WO2012135137A2/en not_active Ceased
- 2012-03-26 EP EP12764327.8A patent/EP2689017A4/en not_active Withdrawn
- 2012-03-26 CN CN201280016692.8A patent/CN104039964A/zh active Pending
- 2012-03-26 BR BR112013024630A patent/BR112013024630A2/pt not_active IP Right Cessation
- 2012-03-26 CA CA2827774A patent/CA2827774A1/en not_active Abandoned
- 2012-03-26 KR KR1020137027719A patent/KR20140043890A/ko not_active Withdrawn
- 2012-03-26 MX MX2013010872A patent/MX2013010872A/es unknown
- 2012-03-26 JP JP2014502663A patent/JP2014518611A/ja active Pending
- 2012-03-26 US US13/430,381 patent/US9506072B2/en not_active Expired - Fee Related
-
2013
- 2013-08-20 IL IL228039A patent/IL228039A0/en unknown
- 2013-08-26 ZA ZA2013/06420A patent/ZA201306420B/en unknown
- 2013-09-24 GT GT201300220A patent/GT201300220A/es unknown
- 2013-09-24 NI NI201300094A patent/NI201300094A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012135137A2 (en) | 2012-10-04 |
| IL228039A0 (en) | 2013-09-30 |
| CN104039964A (zh) | 2014-09-10 |
| SG193356A1 (en) | 2013-10-30 |
| WO2012135137A3 (en) | 2014-05-08 |
| NI201300094A (es) | 2014-02-28 |
| JP2014518611A (ja) | 2014-08-07 |
| US20120244622A1 (en) | 2012-09-27 |
| ZA201306420B (en) | 2014-12-23 |
| MX2013010872A (es) | 2014-02-28 |
| AU2012236811A1 (en) | 2013-09-12 |
| EP2689017A4 (en) | 2015-06-03 |
| GT201300220A (es) | 2015-12-01 |
| KR20140043890A (ko) | 2014-04-11 |
| CA2827774A1 (en) | 2012-10-04 |
| EP2689017A2 (en) | 2014-01-29 |
| US9506072B2 (en) | 2016-11-29 |
| PH12013501901A1 (en) | 2013-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012028805A2 (pt) | composições de endorribonuclease e métodos de uso das mesmas. | |
| BR112013010856A2 (pt) | teste para gardnerella vaginalis | |
| WO2014022702A3 (en) | Methods and compositions for controlling gene expression by rna processing | |
| BRPI0817299A8 (pt) | vacinas e componentes de vacina para inibição de células microbianas | |
| BR112015004995A2 (pt) | loci de desempenho de fad3 e proteínas de ligação específica ao sítio alvo correspondente capazes de induzir quebras direcionadas | |
| BR112018009098A8 (pt) | métodos e composições para edição genética em células-tronco hematopoiéticas | |
| BR112014008152A2 (pt) | método para produção de uma proteina de interesse cultivando uma linhagem celular eucariótica recombinante compreendendo uma construção de expressão compreendendo um promotor regulável e uma molécula de ácido nucleico que codifica uma poi sob o controle transcricional de tal promotor | |
| BRPI1016133A2 (pt) | vacina, método para dispensar um antígeno a um mamífero, composição, métodos para dispensar sirna dentro de células que apresentam antígeno profissionais, para inibir a proliferação de células de tumor, e para dispensar um ácido nucleico a uma célula. | |
| BR112014008775A8 (pt) | Métodos para produzir camundongos com locus restrito de cadeia pesada de imunoglobulina, para obter célula ou tecido de camundongos, para produzir sequência de ácido nucleico que codifica domínio variável de cadeia pesada humano, bem como ácido nucleico | |
| BR112017009835A2 (pt) | moléculas de ácido nucleico artificiais | |
| UY35456A (es) | Moléculas de unión para bcma y cd3 | |
| BR112012004823A8 (pt) | Anticorpo ou fragmento de ligação de antígeno do mesmo, uso de um anticorpo ou um fragmento de ligação de antígeno do mesmo, e composição farmacêutica | |
| BR112015028493A2 (pt) | Métodos para preparar células t para imunoterapia, célula t isolada, seu uso e composição farmacêutica | |
| BR112014027578A2 (pt) | método em um sistema de processamento de dados para gerar uma linha de base de uso de energia, sistema de processamento de dados configurado para gerar uma linha de base de uso de energia e meio legível por computador não transitório | |
| BR112015008708A2 (pt) | composição para clivagem de dna alvo compreendendo um rna guia específico para o dna alvo e ácido nucleico que codifica proteína cas ou proteína cas e uso da mesma | |
| CL2009000082A1 (es) | Acido nucleico que codifica anticuerpos anti cd79a o anti cd79b para el tratamiento de tumores hematopoyeticos; vector y células huésped que los comprenden; polipeptido codificado por dicho acido nucleico, inmunoconjugado con el cuerpo. | |
| BR112015017354A2 (pt) | método para detectar pelo menos uma base modificada | |
| BR112014004543A2 (pt) | método de síntese de proteínas | |
| BR112015004467A2 (pt) | método para controlar a heterogeneidade de proteínas | |
| AR093446A1 (es) | Anticuerpos de antihemaglutinina y metodos de uso | |
| AR089752A1 (es) | Anticuerpos anti-lrp5 y metodos de uso | |
| BRPI0810418A2 (pt) | Membros de ligação alvo, ácido nucléico isolado, vetor de expressão, célula hospedeira, composição, métodos para produzir um membro de ligação alvo, para o tratamento ou prevenção de asma e para produzir um anticorpo contra il-25 | |
| BR112013002634A2 (pt) | sistemas e métodos de precisão aprimorada para correção de temperatura de resultados de glicose para solução de controle | |
| CL2012001143A1 (es) | Anticuerpo anti-fractalkina (anti-fkn); composicion farmaceutica que comprende dicho anticuerpo anti-fkn; acido nucleico; vector; celula huesped; uso del anticuerpo anti-fkn para tratar trastornos inflamatorios. | |
| BR112013018751A2 (pt) | método de cultura de célula animal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |